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ABSTRACT
Importance and Objective: Physical function limitations affect approximately one
fifth of middle-aged women. However, correlates of these limitations are poorly
understood; limited research investigates the associations between menopausal status,
physical function, physical activity, and body composition, and the research available
is equivocal about these associations. Methods: Using a cross-sectional approach, 107
(53.31 ± 6.14 yr) middle-aged women completed six objective assessments of physical
function (transfer task, 8-foot up-and-go, 30-second chair stands, 6-minute walk test,
lift and carry, and lower extremity physical function composite score) and one
subjective assessment of physical function (36-Item Short Form Survey physical
functioning subscale). Muscular strength was measured using handgrip dynamometry.
Physical activity (average steps per day, average minutes of moderate plus vigorous
physical activity per day, and average minutes of total physical activity per day) was
measured via accelerometry. Body composition (percent fat and percent mineral-free
lean mass) was measured with Dual Energy X-Ray Absorptiometry. Women selfidentified menopausal status (premenopausal, perimenopausal, and postmenopausal).
Discussion: Age was significantly different between menopausal status groups
(p<0.05). When controlling for age and number of chronic medical conditions, no
significant differences between menopausal status groups were found for any
outcomes (all p>0.05). In a multiple linear regression controlling for number of
chronic medical conditions, menopausal status was not significantly associated with
any outcome (all p>0.05). However, age was independently associated with two

outcomes: (1) transfer task time (p=0.015), explaining 11.1% of observed variability,
and (2) handgrip strength (p=0.002), explaining 14.7% of observed variability.
Conclusion: Middle-aged women, regardless of menopausal status, have similar body
composition, physical activity levels, and physical function ability.
Key Words: Menopausal status – Middle-age – Physical function – Physical activity –
Body composition – Grip strength.
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CHAPTER 1

INTRODUCTION
A major health concern associated with aging is physical function
performance. Physical function performance, often referred to as “functional ability”
or simply “physical function”, is an individual’s ability to perform basic actions
involving strength, mobility, and endurance that are essential for maintaining
independence and carrying out more complex activities (1).
Physical function is not only an issue impacting older adults (those ≥65 years
of age): there is evidence that men and women experience declines in physical
function during middle-age (approximately ages 40-64). An estimated 18-22% of this
population has significant physical function limitations (2,3), with a higher percentage
of women experiencing limitations compared to age-matched men (2). Recent
evidence suggests that these physical function limitations are associated with health
issues earlier in life than previously thought; a study of 45-year-old men and women
showed that slower gait speed (a measure of physical function) is associated with
markers of poorer cognitive health (such as lower IQ and smaller brain volume), as
well as accelerated biological aging across multiple organ systems (4). Therefore, it is
important to assess for and treat physical function limitations that might occur in
middle-age (5).
Resolving any issues in physical function during middle-age may be important
for preserving physical function in older adulthood (6). While adequate physical
function ability is important at all ages, it is of particular significance for older adults.
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Physical function is a significant determinant of their ability to “age in place”, or to
continue to live independently despite health issues often associated with advancing
age (7). Previous studies in older adults show that age, physical activity, and body
composition are associated with physical function performance (8,9). Further, with
increased age, older adults experience a decline in physical activity level (10), an
increase in adipose tissue (11), a decrease in lean mass (11), and a decline in
functional ability (9). These age-related changes tend to be more pronounced in
women, with more women than men experiencing physical function limitations (12).
This gender gap may be due to older women tending to have lower physical activity
levels (12) and higher prevalence of depressive symptoms (12), arthritis (13), and
obesity (13) compared to age-matched men.
In addition to physical function, many other aspects of health seem to decline
in middle-age. For example, during middle-age in both genders, age has a positive
linear association with number of total health deficits including long-term disability
and arthritis (14). Additional health changes in middle-aged women are associated
with menopause, which typically begins when a woman is in the mid-40s, and is
marked by the permanent cessation of menstruation due to loss of ovarian follicular
activity (15). Menopause is driven by hormonal changes such as decreased estradiol
(E2) and increased follicle stimulating hormone (FSH) and is associated with health
issues including fatigue, anxiety, depression, dips in cognitive performance, loss of
bone mineral density, increases in body fat, lower physical activity levels, and worse
physical function (5). Menopausal status has many categorizations but can be most
simply divided into “premenopausal”, “perimenopausal”, and “postmenopausal”. Most
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measures of menopausal status are self-report measures, which ask women about the
frequency and regularity of their menstrual period. This study utilized the Study of
Women’s Health Across the Nation (SWAN) criteria, a frequently used self-report
definition of menopausal stages.
Despite the number of health changes associated with middle-age in women,
research in this population is limited for a number of reasons. Middle-aged women
experience hormonal fluctuations in both the short term (days to weeks) due to
menstrual cycles, and in the long term (months to years) due to menopause (5). There
are indications that these hormonal fluctuations are correlated with body composition,
physical activity, physical function, and other variables studied in the field of exercise
science (16), possibly explaining why males account for 61% of subjects in exercise
science research (17). Furthermore, middle-aged women have a high potential for
pregnancy, which can make it possibly unsafe for subjects to perform certain
procedures, including Dual Energy X-Ray Absorptiometry (DXA) assessments of
body composition (18). Pregnancy can also impact physical activity levels and
physical function (19), making pregnant women not representative of the overall
population of middle-aged women. Finally, researchers often have difficulty sampling
middle-aged adults due to time constraints including juggling work with caregiving for
children or elderly parents (6). Conversely, young adults are easy to recruit from
universities, and older adults are easy to recruit through senior housing, senior
organizations, or healthcare providers’ offices.
Despite the low volume of research in middle-aged women, research
completed in the last decade is beginning to fill in some of the gaps in knowledge. For
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example, the associations between age and physical function, physical activity, and
body composition in this population have been investigated (9,10,20–23). The
majority of research suggests that, with increased age, middle-aged women experience
decreased physical function (9,20), decreased physical activity (21), increased
sedentary time (10), and increased subcutaneous and visceral abdominal fat (22,23).
Associations between menopausal status and physical function, physical
activity, and body composition are less clear, due to lack of research and measurement
technique standardization. There are preliminary indications that reduced physical
function is associated with menopausal status. Specifically, when controlling for age
and a variety of other potential covariates in middle-aged women, self-reported
menopausal status is associated with the objective physical function measures of 3
stair ascent time (24), sit-to-stand time (24), and maximal gait velocity (24) as well as
the strength outcome of handgrip strength (25–27) and the self-report physical
functioning outcome of the 36-Item Short Form Survey (SF-36) physical functioning
subscale (24,28,29). However, there are conflicting results, showing that when
controlling for age, there are no significant associations between self-report
menopausal status and the physical function measures of natural gait velocity (26,28),
single-leg stand time (25), and repeated chair stands (25,26). Furthermore, when
controlling for age, menopausal status measured using hormonal methods was
associated with handgrip strength, but not associated with maximal gait velocity and
6-minute walk test performance (16).
There are also indications that negative changes in body composition like
increased visceral abdominal fat (22,30), increased total fat mass (31), and decreased
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lean mass (31) are associated with menopausal status when controlling for age.
However, most research using body mass index (BMI) as a body composition estimate
has found no associations with menopausal status when controlling for age (32,33).
Finally, there are preliminary indications that, even when controlling for age,
the menopausal transition is associated with reduced physical activity levels when
using accelerometry (34). However, other studies have found no association between
menopausal status and physical activity that has been self-reported (16,26).
Overall, the findings regarding the associations between menopausal status and
physical function, physical activity, and body composition are often inconsistent in
their methods and results. Thus, the differences in age, physical function ability,
physical activity levels, and body composition among premenopausal,
perimenopausal, and postmenopausal women are not well characterized. Furthermore,
it is not known to what degree changes in physical function and the associated
variables of physical activity and body composition observed during middle-age are
related to menopausal status versus chronological age. Therefore, more research is
needed to clarify the relationships between menopausal status and physical function,
physical activity, and body composition in middle-aged women.
Thus, the primary aim of this study is to describe the differences in age,
physical function performance, physical activity, and body composition among
premenopausal, perimenopausal, and postmenopausal women. The primary hypothesis
is that there will be significant differences in age, physical function, physical activity,
and body composition among the three menopausal groups. Specifically, physical
activity levels, lean mass, and physical function performance will decrease as women
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progress through the menopausal transition, whereas age and fat mass will increase as
women progress through the menopausal transition.
The secondary aim of this study is to examine the strength of the independent
associations between menopausal status and chronological age and physical function
performance, physical activity, and body composition in middle-aged women. It is
hypothesized that compared to chronological age, menopausal status will be more
highly associated with physical function performance, physical activity, and body
composition in middle-aged women.
Through these aims, this study will build on the existing literature by adding
measures of physical function that have been previously unstudied in relation to
menopausal status (transfer task, 8-foot up-and-go, 30-second chair stands, and liftand-carry), as well as previously studied measures (6-minute walk test, handgrip
strength, and the SF-36 physical functioning subscale) in order to provide a
comparison with existing research. Further, it will add to the single study comparing
accelerometer-measured physical activity between menopausal groups (34) and will
help clarify differences in BMI, fat mass, and lean mass that have exhibited little
agreement in previous studies (22,30–33,35–41). Finally, by examining the
associations between age and menopausal status with physical function, physical
activity, and body composition, this study will help clarify the potential contributors to
negative changes in health often seen in middle-age.
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CHAPTER 2

REVIEW OF LITERATURE

Introduction:
Advanced age is associated with many health issues including decreased
physical function, decreased physical activity, and poorer body composition; while
these are often seen as issues only impacting older adults (those 65 and older), middleage (ages 40-64) may actually be the time in which these factors begin to worsen
(2,3,10,20–22,35). Therefore, middle-age may offer an opportunity to prevent or delay
detrimental changes in health (6). Middle-age is also a unique physiological time for
women as this is when menopause occurs, which, in addition to age, also seems to
negatively impact health in many ways, ranging from increased anxiety, depression,
fatigue, and lean mass to decreased physical activity, physical function, and fat mass
(5). Despite the potential for middle-age to be an optimal time to promote healthy
behaviors in women before they worsen during older adulthood (6), women are
understudied in exercise science (17). Specifically, there are many gaps and little
agreement in the literature regarding the associations between menopausal status and
physical function (16,24–29), physical activity (16,26,34), and body composition
(31,42,43) in middle-aged women. The following literature review explores the
existing evidence regarding the relationships between age, menopausal status, physical
function ability, body composition, and physical activity levels.
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Defining Menopausal Status:
Menopause is the permanent cessation of menstruation, resulting from the loss
of ovarian follicular activity, typically beginning around age 45 (15). A variety of
characteristic hormonal and physiological changes occur throughout the menopausal
transition. Notably, El Khoudary et al. (5) performed a recent review of studies
utilizing data from the longitudinal project, the Study of Women’s Health Across the
Nation (SWAN), following middle-aged women to explore the relationship between
menopause and many of its covariates, including hormonal change. They found that
decreases in estradiol (E2) start approximately 2 years before the final menstrual
period (FMP), and continue for two years afterwards (44). Further, follicle stimulating
hormone (FSH) increases from approximately 7 to 2 years before the FMP, with these
patterns in hormonal change stable across body composition, race, and age of FMP
(44). Driven by these hormonal changes, menstrual cycle length increases over the
course of the menopausal transition starting approximately 7.5 years before the FMP
and accelerating around 4 years before the FMP, with different trends in menstrual
cycle change seen in different races/ethnicities as well as in different ages of
menopausal transition onset (45).
Burger et al. (15) offers a more comprehensive exploration of the hormonal
changes during menopause, finding a variety of other changes in addition to those
discussed above (44,45). Using data from the Melbourne Women’s Midlife Health
Project, another large longitudinal study following middle-aged women, Burger et al.
found that an early hormonal signal of menopause is a decrease in inhibin B and antiMullerian hormone (AMH), leading to the increase in FSH and decrease in E2, as well
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as an increase in luteinizing hormone (LH) and the failure of LH to surge in response
to estrogen, which would normally stimulate ovulation (15).
Although age and menopausal status are related, there are a host of other
factors associated with the timing of the menopausal transition besides chronological
age. For example, when controlling for socioeconomic and health status, later age of
the final menstrual period (FMP) is significantly associated with higher level of
education, higher weight, past oral contraceptive use, present employment, not
smoking, consuming alcohol less frequently, being less physically active, and having
better self-reported health, although timing of the FMP is not associated with
race/ethnicity (41). Furthermore, studies in Iran (46) and Finland (47) have found that
mean age at menopause is increasing over time across the world. Specifically, for
Iranian women born in the 1930’s, the mean age of menopause was 48.5, increasing to
49.9 for women born in the 1950’s (46), and in Finland mean age at menopause was
50 in 1997, increasing to 51 in 2007 (47). This indicates that the relationship between
age and menopausal status is changing over time, and therefore age is not a standalone
predictor of menopausal status and its correlates such as physical function.
Hormonal changes drive a variety of symptoms during the menopausal
transition, which can also impact physical function (48). Lovejoy et al. (2008) found
that the menopausal transition is associated with negative metabolic changes as it
progresses (22). Specifically, when following premenopausal women for 4 years and
comparing those who remained premenopausal at follow-up with those who became
postmenopausal, both groups experienced decreased energy expenditure during
waking hours (daily energy expenditure) and decreased energy expenditure during
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sleep (sleeping energy expenditure); however, these decreases were larger in those that
became postmenopausal (9.3% decrease in daily energy expenditure compared to a
7% decrease in those that remained premenopausal, and a 7.9% decrease in sleeping
energy expenditure compared to a 5.3% decreases in those that remained
premenopausal), although differences were not significant (p>0.05). Additionally,
there was a significant decrease in fat oxidation (32.4%, p<0.05) in women who were
postmenopausal at follow up, but no significant change (9.8% decrease, p>0.05) in
those remaining premenopausal.
Vasomotor symptoms (hot flashes and night sweats) are also a common
symptom during menopause. Vasomotor symptoms were reported by 80% of SWAN
participants (49). This number is impacted by race and ethnicity as well as
socioeconomic status, as Black women report worse and more prevalent symptoms
than White and Hispanic women, Asian women report the least symptoms, and
women of lower socioeconomic status report worse and more symptoms regardless of
race (49). Significant associations between the menopausal transition and increases in
reported sleep difficulties, depressive symptoms, anxiety, poor cardiovascular health,
decreased bone mineral density, and decreased sexual functioning have also been
reported by studies examining SWAN data (5).
In addition to physiological factors, researchers have also found that the social
determinants of health during menopause impact this transition in middle-aged women
(50). Menopause and the loss of youth it signifies are generally seen as negative in
western cultures, however, in other countries such as Iran and China, there are more
positive perceptions of menopause and these positive attitudes are associated with
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improved quality of life during this transition (50). Notably, the severity of
menopausal symptoms and quality of life during menopause can be impacted
indirectly by cultural influences on diet, body composition, smoking, and exercise
(50). Practicing a religion, increased social support, increased level of education, and
being married are also associated with lower severity and improved perceptions of
menopausal symptoms, underscoring the impact of women’s emotional and mental
health on their physical health during middle-age (50). Importantly, menopausal
symptoms such as depressive symptoms have been associated with poorer physical
function in middle-aged women and therefore might account for some of the
differences in physical function observed between menopausal status groups (28).
Menopausal status has a variety of categorizations utilizing different phases
and sub-phases. However, menopausal status is most simply divided into
premenopausal, perimenopausal, and postmenopausal. Menopausal status can be
assessed as a self-report bleeding measure as in this study, or via blood draws looking
at FSH and other biomarkers (15). Self-report bleeding measures of menopausal status
involve asking women about the frequency and regularity of their menstrual period.
This study utilized the SWAN criteria, the most frequently used definition of
menopausal stages in existing literature. Like the majority of preexisting literature, this
study combined both perimenopausal stages (stages 2 and 3). The SWAN criteria is as
follows: stage 1) premenopausal is defined as no change in menstrual bleeding
patterns; stage 2) early transition/perimenopause is defined as a change in length of
bleeding or the interbleed interval; stage 3) late transition/perimenopause is defined as
amenorrhea (no menstrual bleeding) for the last 3-11 months; and stage 4)
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postmenopause, which is divided into natural postmenopause, defined as amenorrhea
for the past 12 months not due to hysterectomy (surgical removal of the uterus), and
surgical postmenopause, defined as a bilateral oophorectomy (surgical removal of the
ovary) with or without hysterectomy (5).
An additional self-report measure of menopausal status is the Staging of
Reproductive Aging Workshop (STRAW) criteria, born out of an expert consensus
between researchers in predominant studies of menopause and clinicians (51). This
criteria uses the same four stages as stated above for the SWAN criteria, with slightly
different definitions: premenopause is defined as regular menstrual cycles with no
change in cycle length, early transition is defined as a persistent difference of seven or
more days in consecutive menstrual cycle, late transition is defined as 2-11 months of
amenorrhea, and postmenopause is defined again as no menstrual bleeding for 12 or
more months.
Gracia et al. (52) created the PENN-5 criteria, a third definition of menopausal
status based on self-reported menstrual bleeding. This criteria adds a fifth stage (late
premenopause) to attempt to define more subtle changes seen at the start of
menopause. This definition states that premenopause involves regular menstrual
cycles with no change in cycle length, late premenopause involves a persistent
difference of seven or more days in consecutive menstrual cycle, early transition
involves at least two cycle length changes of at least 7 days, late transition involves 311 months of amenorrhea, and postmenopause involves at least 12 months of
amenorrhea. This study also found that the new stage of “late premenopause” was
associated with a significant drop in inhibin B and a significant rise in FSH,
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suggesting that significant hormonal changes occur early in the menopausal transition,
even with very minor changes in cycle length.
Menopausal status can also be defined using hormonal levels, which requires a
more invasive approach. A popular method for this involves using an algorithm from
the Women’s Ischemia Syndrome Evaluation (WISE) study, which uses fasting blood
draw measures of E2 and FSH as well as time since last menstrual period (LMP), age,
and history of hysterectomy or oophorectomy in a complex algorithm to determine
whether a woman is premenopausal, perimenopausal, or postmenopausal (53).
There is little research into the agreement between self-report measures and
hormonal measures of menopausal status. However, one study found 76.7%
concordant classification between SWAN and WISE criteria when examining 3,000
middle-aged women, and 72.7% concordant classification when looking at the same
sample five years later (54).
Overall, age is not a standalone predictor of menopausal status, as ANM is
changing over time (46,47) and is associated with a variety of socioeconomic and
physiologic conditions (41). Further, the symptoms associated with menopause are
highly variable due to a variety of socioeconomic and physiologic influences (41), and
these symptoms can influence physical function (48). Therefore, it may be prudent to
compare the differential impact of menopause and chronological age on indicators of
health in middle-aged women, such as physical function performance, physical
activity, and body composition.
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Physical Function Performance in Middle-Age: Relationships with Age
Physical function is an individual’s ability to perform basic actions involving
strength, mobility, and endurance that are essential for maintaining independence and
carrying out more complex activities (1). Adequate physical function ability is often
perceived as only important for older adults, however many middle-aged adults
experience limitations in physical function (2,3), emphasizing a need to examine these
outcomes across the lifespan. It is also important to note that there may be small but
statistically significant sex differences in physical functional ability across middle and
older age. For example, Gardener et al. (2) surveyed a sample of 11,216 middle-aged
(50-64) British adults and found that 19% of women self-reported a functional
limitation in mobility (walking), in this case difficulty walking a quarter of a mile,
compared to 18% of men of the same age.
Similarly, Brown et al. (3) found evidence of physical function limitations in
middle-age, with 22% of 6,874 subjects aged 50-64 developing self-reported
limitations in activities of daily living (ADLs), a measure of physical function. The
most common ADL impairment reported was difficulty dressing (14%). This study
demonstrated the potential for these functional declines to accelerate with age, but also
highlighted the potential for reversing these declines; when a 2 year follow-up was
performed after subjects initially reported ADL impairment, 4% had died, 9%
experienced additional ADL decline, and 50% had sustained ADL impairment, but
37% were able to recover functional abilities. Similar patterns were observed with
independent activities of daily living, another measure of physical function.

14

Most recently, Hartmann Rasmussen et al. (4) suggests that physical function
may impact health even at the very beginning of middle-age; a study of 904 45-yearold men and women showed that slower gait speed during a 6-meter walk (a measure
of physical function) is associated with markers of poorer cognitive health (such as
lower IQ [β 0.23, p<0.001] and smaller brain volume [β 0.10, p=0.02]), in addition to
accelerated biological aging across multiple organ systems (β -0.27, p<0.001). This
indicates that interventions to improve physical function in middle-age may offer both
immediate and long-term benefits.
In older adults, it is well established that physical function declines, and that
this decline is more pronounced in women than in men (55,56). A survey of nearly
2,000 men and women ages 65 to 74 in five sites across the globe assessed selfreported mobility difficulty (difficulty walking 400m or climbing stairs), self-reported
ADL disability (difficulty performing at least one ADL), and the short physical
performance battery (SPPB), a set of physical function tasks (12). In four out of five
sites, women had significantly higher incidence of mobility difficulties and ADL
disabilities, and performed significantly worse on the SPPB compared to men (p<0.05
for all) (12). Even after controlling for age, chronic diseases, education, sufficiency of
income, and depressive symptoms, the differences between male and female results
remained significant for mobility difficulties.
Leigh et al. (9) examined longitudinal self-report physical function data for
over 4,500 women and found four distinct patterns for change in physical function
with age in older women (73-90). Physical function was assessed using the self-report
SF-36 physical functioning subscale. Physical function groups ranged from poor initial
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physical function worsening further over time, to high initial physical functioning
worsening slightly over time. Self-reported exercise level was the strongest predictor
of physical function groups (odds ratio for “high” exercisers being in the lowest
physical function group compared to the highest was 0.04). All four of these physical
function groups experienced significant declines in physical function with time,
demonstrating the adverse impact of age on physical function.
In middle-aged women, Ward-Ritacco et al. (20) explored the relationship
between physical function and age. In 64 postmenopausal women ages 45 to 65, age
was a significant independent predictor of both 8-foot up-and-go (F=3.47, p=0.009)
and 30-second chair stand (F=4.95, p=0.001), but not 6-minute walk test performance
(p>0.05). Other significant predictors of the 8-foot up-and-go were muscle quality and
leg power, whereas other significant predictors of the 30-second chair stand were
muscle quality and leg strength. Significant predictors of the 6-minute walk test
included muscle quality, leg strength, total number of medical conditions, steps per
day, and adiposity.
It is clear that declines in physical function impact older adults, however recent
research suggests that around one fifth of middle-aged adults are also impacted (2,3).
There is a decline in physical function seen with age, including throughout middle-age
(9,10,20), and there is evidence that this decline is associated with poorer health (4).
Therefore, there is a need to better understand the correlates of physical function in
middle-aged women, enabling healthcare professionals to improve physical function
and prevent associated adverse health outcomes in this population.
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Objectively Measured Physical Function Performance in Middle-Age:
Relationships with Menopausal Status
While physical function clearly declines with age, it is less clear to what
degree physical function changes are associated with menopausal status. Additionally,
it is not well understood which measures of physical function have an association with
which measures of menopausal status. Establishing these associations may provide
insight into the causes of decreased physical function often observed during middleage in women. Several studies have investigated the associations between menopausal
status and objective measures of physical function (16,24–27), with all studies finding
at least one significant association between menopausal status and a measure of
physical function (most frequently handgrip strength) when controlling for age.
Cooper et al. (25) examined the associations between self-reported menopausal status
and timing of hysterectomy (surgical menopause) with muscular strength (handgrip
strength), balance (single-leg stance time with eyes closed) and physical function
(time to complete 10 chair stands) in 1,386 53-year-old British women who were not
undergoing hormone replacement therapy (HRT). They found that postmenopausal
women had weaker handgrip strength than premenopausal and perimenopausal women
(p=0.07), although this difference was not statistically significant, even when
accounting for body size (p=0.12). For those who underwent surgical menopause,
lower age at hysterectomy was significantly associated with lower grip strength
(p<0.05), even after adjustment for covariates including height and weight at age 53,
father’s occupational class, head of household occupational class, cognitive function at
age 8, smoking status at age 53, hormone therapy, and parity at age 53. There were no
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significant associations between either menopausal status or timing of hysterectomy
and chair rise or standing balance time (p>0.05).
Similarly, Da Câmara et al. (26) explored the relationship between menopausal
status and physical function in 389 Brazilian women ages 40 to 65 years. Menopausal
status was self-reported according to the STRAW criteria. Muscular strength
(handgrip strength) and physical function (a 4-meter walk at the subject’s natural pace
and time to complete 5 chair stands) were objectively measured. When adjusting for
age, premenopausal women had higher handgrip strength (p=0.036) and faster chair
stand times (p=0.29) compared to perimenopausal and postmenopausal women, but
there were no statistically significant differences in gait speed between groups
(p=0.91). However, once additional covariates (socioeconomic status, BMI, walking
time per week, sitting time per week, reproductive history, and hypertension) were
included, only the difference in grip strength remained significant, with
premenopausal women having significantly higher grip strength than postmenopausal
women (p=0.019).
Kurina et al. (27) examined 564 SWAN study participants ages 42-52 at
enrollment and at a 3-year follow-up. Menopausal status was defined according to the
SWAN criteria. Outcome measures were handgrip strength and pinch strength.
Statistical analysis adjusted for age, BMI, income, smoking status, and physical
activity level. Compared to women who remained premenopausal at follow-up,
women who became postmenopausal by follow-up showed a 1.04 kg decline in grip
strength (although this was not statistically significant, at p=0.10) and a 0.57 kg
decline in pinch strength (p=0.002), women who became early perimenopausal
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showed a 0.20 kg decline in pinch strength (p=0.04), and women who transitioned to
late perimenopause showed a 0.93 kg decline in grip strength (although this was not
statistically significant, at p=0.07).
The Estrogenic Regulation of Muscle Apoptosis (ERMA) study by Bondarev
et al. (16) used a cross-sectional design to further investigate associations between
physical function and menopausal status in 903 Finnish women ages 47 to 55. Unlike
the previous studies, menopausal status was determined with the use of fasting serum
samples of FSH levels, in combination with self-reported menstrual cycle regularity
according to the STRAW criteria. Handgrip strength and physical function (maximal
walking speed over 10 meters and 6-minute walk test distance covered) were
measured. After controlling for age, fat mass, height, physical activity, and education,
the only significant association found between these variables was that
postmenopausal women had lower handgrip strength (p<0.001) compared to
premenopausal women.
As part of the Michigan Bone Health and Metabolism Study, Sowers and
Tomey et al. (24) explored the relationship between physical function and menopausal
status in 530 middle-aged women (mean age 44.8±4.8) as a part of a 5-year
longitudinal study. Menopausal status was self-reported using the following stages:
premenopausal (10 or more menstrual cycles in the past 12 months), perimenopausal
(9 or less menstrual cycles in the past 12 months), and postmenopausal (no menstrual
period in the last 12 or more months). Physical function measures included the SF-36
physical functioning subscale, 40-foot brisk walk velocity, timed 3-stair ascent, and
time to stand from being seated in a chair. Handgrip strength was also assessed.

19

Controlling for age, BMI, and smoking status, women who underwent natural
menopause had significantly poorer hand grip strength (p<0.0005), walk velocity
(p<0.05), and SF-36 physical functioning scores (p<0.05) compared to women who
were premenopausal and women who were perimenopausal at the 5-year follow-up.
With the same control variables, women who underwent menopause surgically with
hormone replacement or ovary conservation had significantly poorer walk velocity
(p<0.05), SF-36 physical functioning scores (p<0.01), chair stand time (p<0.01), and
stair ascent time (p<0.01) compared to premenopausal and perimenopausal women.
Again with the same control variables, women who underwent menopause surgically
without hormone replacement also had significantly poorer walk velocity (p<0.05),
SF-36 physical functioning scores (p<0.01), chair stand time (p<0.01), and stair ascent
time (p<0.01) compared to premenopausal and perimenopausal women. These
findings indicate that, regardless of whether menopause occurs naturally or surgically
and regardless of hormone replacement or ovary conservation, physical function tends
to be worse in postmenopausal women compared to premenopausal and
perimenopausal women.
The findings from these studies (16,24–27) indicate that perhaps muscular
strength as measured by hand grip strength may be the first physiological factor to
change as a result of menopause. This change in muscular capacity may occur first and
over time, resulting in the changes in balance and physical function that are observed
in some of these studies. The present study looks at handgrip strength and a variety of
objective physical function tasks, and may aid our understanding of whether or not
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changes in handgrip strength occur in tandem with changes in physical function
performance over the menopausal transition.
Subjectively Measured Physical Function Performance in Middle-Age:
Relationships with Menopausal Status
The present study also incorporates a subjective (self-reported) measure of
physical function in order to compare results with objective measures of physical
function. Several studies have explored only subjective measures of physical function
and their association with menopausal status (28,29). In 2012, Tseng et al. performed a
cross sectional analysis using data from the longitudinal SWAN study (28). 2,236
women ages 45 to 57 self-reported menopausal status according to the SWAN criteria
and completed the SF-36. Physical function limitation was defined as “substantial”
(SF-36 physical functioning subscale scores of 50 or below), “moderate” (scores of
51-85), and “none” (scores of 86-100). The association between menopausal status
and self-reported physical function was assessed while controlling for age, ethnicity,
research site, education, BMI, diabetes, hypertension, arthritis, depressive symptoms,
smoking, and hormone use. Postmenopausal women were over three times more likely
to have substantial functional limitations compared to premenopausal and
perimenopausal women, regardless of whether menopause was natural (odds ratio =
3.82, p<0.05) or surgical (odds ratio = 3.54, p<0.05). However, moderate limitations
in physical function were not associated with menopausal status, as the odds ratio of
moderate limitations compared to premenopausal and perimenopausal women was
1.62 in naturally postmenopausal women and 1.09 in surgically menopausal women
(both p>0.05).
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In 2014, El Khoudary et al. (29) performed a longitudinal study that examined
the associations between menopausal status and subjective physical function in 2,495
women ages 45 to 57 years. Physical function limitations were defined as by Tseng et
al. (“none”, “moderate”, and “substantial”, based on SF-36 physical functioning
subscale scores) (28) and menopausal status was self-reported according to the SWAN
criteria. This study had a median follow-up time of 9.7 years, and data was collected
an average of 4.3 times per person. The study also assessed 24-hour fasting hormone
levels, including serum testosterone (T), E2, and serum hormone-binding globulin
(SHBG). Analyses were controlled for age, race, research site, economic status,
comorbid conditions, final BMI, final physical activity level, and changes in BMI and
physical activity. The odds of having a substantial functional limitation compared to
having no or some limitation were significantly higher in late perimenopausal women,
naturally postmenopausal women, surgically postmenopausal women, and hormoneusing/status unknown women compared to premenopausal and early perimenopausal
women (all p<0.05). Further, lower E2 at visit 4 and less reduction in E2 and T from
visit 4 to visit 12 were significantly associated with lower odds of reporting any
functional limitations (p<0.05). Finally, a greater increase in SHBG from visit 4 to
visit 12 was associated with greater odds of any functional limitations (p<0.05).
Based on this evidence (28,29), there seems to be a significant association
between the SF-36 physical functioning subscale and menopausal status, with
postmenopausal women self-reporting worse and more functional limitations
compared to premenopausal and perimenopausal women, regardless of whether
menopause was natural or surgical. However, there is little research comparing both
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subjective and objective measurements of physical function in relationship to
menopausal status, which is a gap in literature the present study addresses.
Objectively Measured Physical Function Performance in Middle-Age:
Relationships with Age at Menopause
Beyond being associated with menopausal status, it is possible that physical
function is associated with age at menopause. It is important to understand this
association, as it may influence the associations between menopausal status and
physical function. There are few studies available examining the associations between
the age at which menopause occurs and physical function performance (57–59). Velez
and Rosendaal et al. (57) assessed the age at natural menopause (ANM) and physical
function in 775 older women (ages 65 to 74) who underwent natural menopause in
Albania, Colombia, Brazil and Canada. ANM was self-reported as the age of the final
menstrual period (FMP) and divided into 5 categories: <40, 40-44, 45-49, 50-54, and
≥55 years. Handgrip strength and physical function (3-meter or 4-meter gait speed)
were measured. When adjusting for age, years of education, income, height, BMI,
hormone replacement therapy, postmenopausal hysterectomy, smoking status, and
childhood economic and social adversity, with ANM 50-54 as the reference group,
those with ANM ≥55 had a significantly higher gait speed (p=0.005), but not a
significantly different handgrip strength (p=0.493). Additionally, those with ANM <40
had a significantly worse handgrip strength than those with ANM 50-54 (p=0.001).
Velez and Alvarado et. al (58) similarly studied ANM and physical function in
9,920 naturally postmenopausal women aged 45-85 at baseline, using the Canadian
Longitudinal Study on Aging. Handgrip strength and 4-meter walk velocity were
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assessed, and analyses controlled for education, BMI, hormone replacement, smoking
status, age, and study site. With ANM 50-54 as a reference, women with ANM <40
had a significantly slower gait speed (p<0.001) and lower grip strength (p=0.042),
while women with ANM ≥55 had a significantly faster gait speed (p=0.001) and a
significantly higher grip strength (p<0.001).
Finally, Tom et al. (59) assessed 1,765 women from the United States aged
≥60 using cross-sectional data from National Health and Nutrition Examination
Survey (NHANES) III (59). ANM was again self-reported as the age of the FMP, and
divided into 4 categories: <45, 45-49, 50-54, and ≥55. Objective physical function
measures included walking speed at a natural pace over 8 feet and time to complete 5
chair stands. Subjective physical function limitation was defined as having selfreported difficulties in three or more of the following: walking a quarter mile; walking
up 10 steps; stooping, crouching, or kneeling; lifting and carrying up to 10 pounds;
and standing up from an armless chair. After controlling for age, race/ethnicity, height,
weight, education, smoking status, number of children, and use of estrogen therapy,
higher ANM was associated with higher walking speed (p<0.01), while there were no
significant associations between ANM and chair rise time (p=0.79) or ANM and selfreported functional limitation (p =0.06). While the latter was not statistically
significant, these results suggest that later ANM is associated with lower chances of
self-reported functional limitation.
Considering these studies together, some evidence supports a significant
association between age at menopausal onset and objective measures of physical
function performance (with lower age of onset being associated to poorer physical
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function performance in a variety of measures, most often gait speed) (57–59).
However, this association that has not been thoroughly explored, and it would benefit
from further analysis.
Physical Activity: Relationships with Age
Physical activity (PA) can be defined as any movement produced by the body
that results in a significant increase in caloric expenditure above resting levels (60). It
is clear that with age, including across middle-age, physical activity tends to decline
(21) and sedentary time tends to increase (10). This has negative implications for
physical functioning, as it is well established that, in middle-aged and older women,
worse physical function performance is associated with lower physical activity levels
(8,10,11,16,20,22,27,61–63) and increased sedentary time (10).
Physical Activity: Relationships with Menopausal Status
Since physical function performance is associated with physical activity level
in middle-aged women (10,61), it is important to discuss how physical activity levels
might change during the menopausal transition. However, independent of age, the
association between menopausal status and physical activity is poorly established
(16,26,34). Bondarev et al. (16) explored this relationship in 903 Finnish women ages
47-55, with menopausal status determined by combination of hormonal levels and the
self-reported STRAW criteria. A self-report 7-point physical activity scale was
subdivided into “low”, “moderate”, and “high” scores. This study found no significant
association between physical activity level and menopausal status (p=0.227).
However, a limitation of this study was that no confounding variables were identified
and controlled for in the analysis.
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Da Câmara et al. (26) also found no significant relationship between
menopausal status and physical activity level in 389 middle-aged Brazilian women
(40-65). Menopausal status was self-reported according to the STRAW criteria.
Physical activity level was self-reported as the total time per week subjects walked for
at least 10 minutes without stopping, with results dichotomized as being <90 minutes
per week and ≥90 minutes per week. Sedentary time was assessed as self-reported
time sitting per day and dichotomized into <4 hours per day and ≥4 hours per day. No
significant associations were found between menopausal status and sedentary time
(p=0.642) or physical activity (p=0.305).
In contrast, Duval et al. (34) found a significant association between
menopausal status and certain measures of physical activity when examining 102
premenopausal middle-aged women followed for 5 years. Menopausal status was selfreported and verified with FSH levels. Categories were defined as “premenopausal”
(no changes in the menstrual cycle frequency), “menstrual transition” (irregular cycles
with variable cycle length >7 days different from normal and/or 2 skipped cycles and
an interval of 60 days of amenorrhea), or “postmenopausal” (FMP over 12 months
ago, with FSH levels >30 IU/L). All subjects were verified to be premenopausal at
baseline, and menopausal status was re-assessed at the 5-year follow-up. Physical
activity level was assessed via accelerometer, which recorded daily energy
expenditure from PA and time spent in sedentary and moderate PA. They found that
time spent in moderate physical activity decreased over the menopausal transition until
the onset of menopause, with the only significant year-to-year difference being that
women 2 years prior to their FMP had a significantly higher level of moderate PA per
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week than women at the year of their FMP (p<0.05). Additionally, time spent in
sedentary physical activity increased across the menopausal transition throughout
postmenopause, with the year before the FMP having significantly lower sedentary
time than the year of the FMP, and the year after the FMP having significantly higher
sedentary time than the year of the FMP (all p<0.05). No significant associations were
found between menopausal status and daily energy expenditure from PA. The results
found by Duval (34) contrast those found by Bondarev (16) and Da Câmara (26),
possibly because the latter two studies did not control for covariates that may have
muted any associations between menopausal status and physical activity.
A major problem with research in this area is that physical activity levels are
self-reported in two of the three studies (16,26), which may lead to errors, as adults
tend to overreport both time and intensity of exercise, with women providing a larger
overestimation of their physical activity compared to men (64,65). Additional research
is needed to support the accuracy of the one study relating menopausal status to
accelerometer-measured physical activity (34), which the present study seeks to
address.
Body Composition: Relationships with Age and Menopausal Status
Body composition has an impact on many areas of health, including physical
function performance, and aging is associated with changes in body composition (66).
Increases in subcutaneous fat and visceral abdominal fat are seen with increased age in
middle-aged women (22) and in women throughout the lifespan (23), while lean mass
has been shown to decrease with age in middle-aged women (35).
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Poorer performance on physical function measures in middle-aged and older
women is associated with higher adiposity (20), lower lean mass (20), lower leg
mineral-free lean mass (MFLM) (67), higher body weight to MFLM ratio (67), higher
visceral fat (22), poorer muscle quality (62), and increased relative adiposity (62).
Thus, it is important to understand changes in body composition with menopausal
status. Unlike physical activity and physical function, there is a large volume of
research describing differences in body composition between menopausal status
groups (31,42,43), although there is little agreement between studies. In the past 5
years, two review articles have compiled the literature regarding this association
(42,43).
The first review article by Al-Safi et al. (42) described the associations
between menopausal status and body composition and found that the associations
between body mass and FMP are inconsistent. A number of studies reported that
indirect estimates of poorer body composition such as higher BMI/weight gain were
associated with later age at natural menopause (68), while other studies reported no
significant associations (69). Furthermore, Al-Safi found that menopausal status is
significantly associated with weight gain in four studies (32,33,36,37), but only two of
these studies found this association to be significantly independent of age (33,37).
When examining body composition with a highly valid direct measure (computed
tomography, or CT), visceral and total body fat increased only throughout
postmenopause, while subcutaneous adipose increased with age across menopausal
stages, indicating that possible differences in fat distribution may occur along the
menopausal spectrum (22). Al-Safi et al.’s review (42) also found that many studies
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were able to attribute a large amount of the weight gain across the menopausal
transition to a reduction in energy expenditure seen during menopause, which is
attributed to a combination of decreased physical activity and hormonal change
associated with the menopausal transition (22). This underscores the importance of
acknowledging the interactive relationships between body composition and lifestyle
behaviors, including physical activity.
Karvonen-Gutierrez et al. (43) provided a second review assessing the
associations between menopausal status and body composition. This review also found
evidence linking obesity to a later age at FMP, specifically when looking at studies
using indirect measures of body composition. The majority of the cross-sectional
studies analyzed found strong evidence for the association between a later FMP and
better body composition via indirect measures such as BMI and weight (38).
Conversely, most longitudinal studies found weak (39) to no (41) association using
such measures; this may be due to inaccuracies in recalling BMI in longitudinal
designs, or may suggest that this relationship is not strong. This review also provides
more information looking at direct measurements of body composition, providing
multiple studies using DXA (22,30), CT (30), and magnetic resonance imaging (MRI)
(30) to reinforce the fact that women have relatively more subcutaneous abdominal fat
prior to the FMP and relatively more visceral abdominal fat after the FMP, reflecting
increased central body fat distribution. Further, this review reports multiple studies
finding a significant association between later menopausal phase and decreased lean
muscle mass using DXA (40) and bioelectrical impedance analysis (BIA) (35).
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Greendale et al. (31) builds on these findings with a longitudinal assessment of
1,246 premenopausal SWAN study participants with mean age 46.66 at baseline. Data
was collected annually, with a mean of 10 visits and a maximum of 13. Menopausal
status was self-reported according to the SWAN criteria, FMP was self-reported,
weight was measured via scale, and body composition was measured via DXA
(specifically reporting total fat mass and total lean mass). Fat mass and lean mass were
found to both increase significantly prior to the start of menopause (1.0% per year
with p<0.0001, and 0.2% per year with p=0.0002, respectively). At the start of
menopause (approximately 2 years prior to the FMP), rate of fat gain doubled and
significant lean mass loss occurred, with both of these trends decelerating
approximately 1.5 years after the FMP but still continuing until 2 years after the FMP.
Overall values for change during the menopausal transition are a 1.7% increase in total
fat mass per year (p<0.0001) and a 0.2% loss in total lean pass per year (p=0.007).
After the FMP, both fat mass gain and lean mass loss decelerated to a zero slope (i.e.
no changes over time) (p≥0.1 for both). Contrastingly, weight and BMI increased
linearly prior to and throughout the menopausal transition (0.3% and 0.4% per year
respectively, both with p<0.0001), with accelerations approximately 1 year before the
FMP, decelerations approximately 3 years after the FMP, and stability after
menopause. This study underscores the potential oversimplification of using indirect
measurements of body composition (such as weight or BMI) to assess changes during
menopause and may provide some explanation of the conflicting results seen with the
studies using these measures in the previously mentioned review articles.
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Despite there being a large volume of research on the relationship between
menopausal status and body composition, it is still difficult to decipher to what degree
the changes in body composition seen in middle-age women are primarily driven by
menopause, aging, or other related lifestyle/behavioral factors. Based on present
evidence, it seems that increases in weight (i.e. increases in BMI) seen during
menopause may be more strongly associated with age than menopausal status, since
BMI is associated with menopausal status (36), but rarely when age is controlled for
(37). On the other hand, changes in fat distribution and lean mass (observed with
direct measurements like DXA, CT, and MRI) may be more strongly associated with
menopause, as increased visceral abdominal fat (22,30,31) and decreased lean mass
(28,58,69) have been shown with advancing menopausal phase, even when controlling
for age. A major limitation of the current research in this area is that the most common
methods of describing body composition are indirect estimates (such as BMI and
waist-to-hip-ratio) and not direct measurement techniques (such as DXA), which
would likely produce more accurate and descriptive results and may change the
observed trends.
Conclusion:
Middle-aged women are understudied in general, and there is especially little
agreement on the associations between menopausal status and physical function,
physical activity, and body composition. From existing literature, there is preliminary
evidence associating more advanced menopausal status with poorer physical function
(16,24–29), lower physical activity (34), and poorer body composition
(22,30,31,35,40) in middle-aged women.
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However, it is difficult to make conclusions about these associations because
there is little commonality in measurement techniques in existing literature. Each
variable has a number of options for measurement: menopausal status can be selfreported by the SWAN, STRAW, or PENN-5 criteria, or measured with blood levels
of hormones such as through the WISE criteria; physical function can use self-report
measures like the SF-36 physical functioning subscale or objective tasks such as the 6minute walk test; physical activity can be self-reported with questionnaires or
objectively measured via accelerometry; body composition can be estimated with
indirect measurements such as BMI or directly measured with tools like DXA. Thus, it
is possible that only certain measures of physical function, physical activity, and body
composition are sensitive enough to detect significant differences between menopausal
status groups, whereas others are not.
Despite these difficulties, it is important to further investigate differences in
physical function, physical activity, and body composition between menopausal status
groups in order to better understand the health of women at all stages of the
menopausal transition. Middle-age may offer an important time frame to improve or
slow the progression of any negative changes in physical function, physical activity,
and body composition before they tend to decline at a more rapid rate in older
adulthood (6). Thus, a better understanding of any negative changes during middle-age
may help to optimize prevention and treatment during this period of life, ideally
leading to improved health in middle-age that continues into older adulthood.
The present study clarifies and adds to existing literature by incorporating
physical function tasks that have been previously unstudied in association with
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menopausal status (transfer task, 8-foot up-and-go, 30-second chair stand, and lift-andcarry), as well as incorporating physical function measures that have been studied in
association with menopausal status (6-minute walk test, handgrip strength, and the SF36 physical functioning subscale) to allow for comparison with existing literature.
Further, it adds to the understanding of associations between menopausal status and
accelerometer-measured physical activity and adds to the equivocal evidence base
examining menopausal status and its association with fat mass and lean mass.
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CHAPTER 3

METHODOLOGY

Participants
A convenience sample was recruited on a rolling basis from 2016 to 2019 via
flyers posted at the University of Rhode Island and in the local community, social
media posts, and word of mouth. Eligibility criteria required participants to be middleaged (40-64 yr), English-speaking women living independently, with BMI values
below 45.0 kg/m2 (the capacity of the DXA scanner in this study). Subjects were
excluded if they were currently smoking (or quit in the past 6 months), were pregnant,
had any diseases or conditions preventing safe study participation, or experienced
weight change of over five pounds in the past three months. Participants also had to be
willing to wear an accelerometer for a seven to ten- day period and participate in a
DXA scan. All study procedures were approved by the University’s Institutional
Review Board (IRB) in October 2016 (board reference number HU1516-206) and all
participants signed an IRB approved informed consent form prior to enrollment in the
study.
Procedures
Interested participants completed an online eligibility survey to determine if
they met basic inclusion criteria. If inclusion criteria were met, these individuals were
contacted via email to schedule two visits to the Human Performance Laboratory at
the University of Rhode Island’s Independence Square building. Visits were separated
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by seven to ten days. During the first visit, participants provided written informed
consent, and completed the Physical Activity Readiness Questionnaire (PAR-Q) and
the Mini-Mental State Exam. Additionally, self-reported menopausal status,
chronological age, and muscular strength and physical function measures were
assessed during visit 1. Participants were then provided with an accelerometer to wear
for seven to ten days and were given a physical activity log.
Visit 2 was conducted seven to ten days after visit 1, to allow for the collection
of objectively measured physical activity data via accelerometry, medical history, and
quality of life. During visit 2, accelerometers were returned, and physical activity logs
were reviewed with participants for any necessary clarification. Further, DXA scans
and measures of muscular capacity assessments were performed during visit 2.
Menopausal Status Assessment
Menopausal status was self-reported utilizing the SWAN criteria but combined
postmenopausal stages (stages 3 and 4), as is the norm in much of present literature
(5). The SWAN criteria is as follows: stage 1) pre-menopausal was defined as no
change in menstrual bleeding patterns; stage 2) early transition/peri-menopause was
defined as a change in length of bleeding or the interbleed interval; stage 3) late
transition/peri-menopause was defined as no menstrual bleeding (amenorrhea) in the
last 3-11 months; and stage 4) post-menopause, which was divided into natural postmenopause, defined as no bleeding in the past 12 months not due to hysterectomy
(surgical removal of the uterus), and surgical post-menopause, defined as a bilateral
oophorectomy (surgical removal of the ovary) with or without hysterectomy (5).
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Chronological Age Assessment
Birth date was self-reported and used to determine chronological age.
Body Composition Assessment
Weight in kg was obtained via a calibrated digital scale (Tanita WB-100,
Arlington Heights, IL) and standing height in cm was obtained via a stadiometer (Seca
213, Chino, CA). BMI was computed with the formula BMI = (weight in kg) / ([height
in m]2). DXA scans were performed by a trained professional using a GE Lunar iDXA
(Waukesha, WI). Fat mass (FM) and mineral-free lean mass (MFLM) were obtained
according to manufacturer’s guidelines and converted into percentages.
Physical Activity Assessment
Physical activity level was measured via ActiGraph accelerometers (Actigraph
GT9XLink, Pensacola, FL) between visits 1 and 2 (seven to ten days). Physical
activity was quantified by average steps per day (steps/day), average minutes spent in
moderate and vigorous physical activity per day (MVPA/day), and average minutes
spent in low, moderate and vigorous activity per day (LMVPA/day). Physical activity
logs were also completed by participants on the days they wore the accelerometer and
compared to accelerometer data to ensure accuracy. To be included in the final data
analysis, participants needed at least 4 valid wear days (a day with at least ten hours of
confirmed wear). This data was analyzed via the accompanying ActiLife software.
Objective Measures of Physical Function
All objective physical function measures were performed by trained personnel
following standardized scripts and using standardized equipment. At least two minutes
of rest were provided between each task. Further, participants were permitted to
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complete a second trial of any functional tasks they chose if they thought they could
improve upon their first trial.
•

Transfer task (TRANSFER): The participant began in a standing position on a
mat. On the command “go”, the participant sat down on the mat and returned
to a standing position in whatever manner they chose as quickly as possible.
Total time was recorded (70).

•

8-foot up-and-go (UPGO): The participant began seated in an armless chair
with its back placed against a stable surface such as a wall. On the command
“go”, the participant stood up and walked around a small plastic cone placed 8feet from the chair and returned to a seated position in the chair as quickly as
possible. Total time was recorded (71).

•

30-second chair stands (STAND): The participant began seated in an armless
chair with its back placed against a stable surface such as a wall. On the
command “go”, the participant rose to a standing position using only the legs,
keeping her arms crossed across her chest. The participant proceeded to return
to a fully seated (i.e. buttocks contacting the chair) position and then fully
standing position as many times as possible in 30 seconds. Total number of full
touches between buttock and chair was recorded (72).

•

6-minute walk test (6MWT): The participant began in a standing position at
the end of a preset course a known distance apart (30 feet). On the command
“go”, the participant walked as quickly as possible, performing laps back and
forth over the preset course in order to cover as much distance as possible in 6
minutes. The participant was instructed to pace herself in order to be able to
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continue walking the entire time, but termination and/or rest breaks were
allowed at any point. The total distance covered (the distance of each pass x
the total number of passes + the distance of the final partial pass) was recorded
(73).
•

Lift and carry (LIFT): The participant began in a standing position at the end
of a preset 20-foot course. A milk crate was placed next to the participant
containing 10 lbs. At the other end of the course, a shelf of standard height
(51.5 inches tall) was placed against a wall. On the command “go”, the
participant lifted the crate using proper lifting technique, walked over the shelf,
placed the crate on the shelf, fully released her grip on it, picked the crate back
up, returned to the starting position, put the crate down, and fully released her
grip on it. The participant completed 5 repetitions of this sequence. Total time
was recorded.

•

Lower extremity physical function composite score (LEPF-CS): Z scores for
the four lower extremity physical function tasks (transfer task, 8-foot up-andgo, 30-second chair stands, and 6-minute walk test) were computed using
SPSS statistical analysis software. Z scores in which a lower score reflected
better physical function (transfer task and 8-foot up-and-go) were reverse
scored by taking the inverse of the Z score. Then, all four Z scores were totaled
to form the lower extremity physical function composite score.

Subjective Measure of Physical Function
The RAND 36-Item Short Form Survey (SF-36) was used to measure healthrelated quality of life and perceived physical function was assessed using the physical
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functioning subscale of the SF-36 (SF-36 PF). This subscale contains ten items that
assess an individual’s perception of their ability to be physically active and complete
activities of daily living on a 3-point Likert scale (yes, limited a lot; yes, limited a
little; and no, not limited at all) (74,75). Previous literature has consistently found an
association between menopausal status and this subscale (24,28,29), and thus it was
included to compare the results of this study with previous literature on the topic.
Muscular Strength Assessment
Muscular strength was estimated via hand grip dynamometry (Jamar
Technologies Hydraulic Hand Dynamometer, Bolingbrook, IL). Maximal handgrip
strength was tested twice bilaterally according to manufacturer instructions. The
average value for the right and left hands were computed and summed for an overall
handgrip score (HGS).
Statistical Analysis
SPSS statistical software version 26.0 for Windows (IBM Corp, Armonk, NY)
was utilized to perform all data analysis. All data was assessed for normal distribution;
outliers in outcome variables (defined as data points falling outside of 3 standard
deviations from the mean) were excluded from the study. Next, descriptive statistics
were calculated for the total sample as well as for each menopausal group. A
multivariate analysis of covariance (MANCOVA) and subsequent post hoc analysis
were used to analyze differences among these groups, with age and total number of
chronic medical conditions as control variables. Finally, linear multiple regression
analysis examined chronological age as an independent predictor of body composition
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(% fat), physical activity, and physical function, while controlling for total number of
chronic medical conditions.
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CHAPTER 4

FINDINGS

180 middle-aged women were screened for participation in this study. Eleven
were deemed ineligible for reasons including, being a smoker (2), not living
independently (1), BMI too large or not weight stable (7), or severe musculoskeletal
disorder (1). Thirty-eight did not respond to follow-up contact, leaving 131 eligible
participants. Four declined participation, therefore 127 scheduled visit 1. Four subjects
chose not to attend and one did not complete visit 1 due to severe hypertension. Two
declined scheduling visit 2 due to the time commitment, therefore 120 completed visit
2. Thirteen subjects were excluded from data analysis because of missing data (10) or
representing outliers 3 or more standard deviations outside of the mean on measures of
physical function (3). Thus, 107 participants were included in the final data analysis.
Table 1 shows participant characteristics for the entire sample (n=107) and
Table 2 shows participant characteristics by menopausal status group (premenopausal
n=22, perimenopausal n=24, and postmenopausal n=61). The sample was 98.13%
white. On average, participants had 3.04 ± 2.50 significant chronic conditions and
regularly took 1.02 ± 1.30 prescription medications and 1.33 ± 2.20 over-the-counter
medications. The sample was overweight (BMI of 25 to < 30 kg/m2) (60) with a mean
BMI of 26.31 ± 5.11 kg/m2. Mean percent fat was 38.04 ± 8.06%, which fell into the
“very poor” classification of percent fat using the American College of Sports
Medicine’s recommendations for women of their age (≥33.4% for women 40-49 and
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≥34.9% for women 50-59) (60). However, the sample’s percent fat was lower than
United States population norms (39.2% for women ages 40-49, 41.7% for women ages
50-59, and 42.4% for women ages 60-69) (76).
When assessing physical activity levels, 78.5% of the sample met the required
four complete wear days (10 hours or more) for the accelerometer. Average wear time
was 6.18 ± 1.06 complete days per person. Only 25.23% of participants met the
recommended 10,000 steps per day (77) and 42.99% achieved an average of at least
30 minutes of moderate to vigorous activity per day.
Figures 2a-2h display MANCOVA findings examining differences in body
composition, physical activity level, and physical function between menopausal status
groups. Controlling for age and total number of chronic medical conditions, no
statistically significant differences between menopausal status groups were found for
any of the outcome variables. As there were no significant between-group differences
found in the MANCOVA, post hoc analysis was not performed. ANOVA found that
age was significantly different between each menopausal status group (p≤0.001 for all
comparisons).
Tables 3a and 3b provide results from multiple linear regression analysis
assessing the independent associations of age and menopausal status with body
composition, physical activity level, and measures of physical function when
controlling for total number of chronic medical conditions. Age was independently
associated with TRANSFER (p=0.015), explaining 11.1% of the variability in
TRANSFER when chronic medical conditions were held constant. The overall model
using age and menopausal status as predictors of TRANSFER, while controlling for
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chronic medical conditions, was significant as well (p=0.001), although menopausal
status was not independently associated with TRANSFER (p=0.876). Similarly, age
was independent associated with HGS (p=0.002), explaining 14.7% of the variability
in HGS when chronic medical conditions were held constant. The overall model was
significant as well (p=0.001), although menopausal status was not a significant
independent predictor of HGS (p=0.500). Menopausal status and age were not
significant predictors of any other outcome variables, and no other models achieved
overall significance (p<0.05).
Tables 4a-4c report correlations between study variables for premenopausal,
perimenopausal, and postmenopausal women when controlling for age, BMI, and total
number of chronic medical conditions. Correlations between study variables vary
greatly when comparing menopausal status groups. For example, the correlations
between measures of body composition and physical activity is stronger for
premenopausal women (Table 4a) and postmenopausal women (Table 4c) compared
to perimenopausal women (Table 4b). Specifically, the correlation (r) between steps
per day and fat mass % is -0.322 in premenopausal women, -0.121 in perimenopausal
women, and -0.313 in postmenopausal women. Similarly, the correlation (r) between
MVPA per day and fat mass % is -0.359 in premenopausal women, -0.191 in
perimenopausal women, and -0.299 in postmenopausal women. Also of note is that the
correlation between the lower extremity physical function composite score and body
composition (percent fat) is stronger in premenopausal women (r=- 0.351) and
postmenopausal women (r=-0.265) compared to perimenopausal women (r=0.039),
although correlations with individual functional tasks is more variable.
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Interestingly, which measure of physical activity is most strongly associated with
the lower extremity physical function composite score varies by menopausal status; in
premenopausal and postmenopausal women it is MVPA/day (r=0.421 and 0.361,
respectively), while in perimenopausal women it is LMVPA/day (i.e. total PA per day;
r=0.628). Relationships between individual measures of physical function and
physical activity is also highly variable between menopausal status groups, with mean
correlations between all measures of physical activity (steps/day, MVPA/day, and
LMVPA/day) and all measures of physical function (transfer task time, 8-foot up-andgo time, 30-second chair stand repetitions, 6-minute walk test distance, lower
extremity physical function composite score, SF-36 physical functioning subscale, and
handgrip strength) being close to 0 for all groups (r=0.108 for premenopausal, 0.042
for perimenopausal, and -0.004 for postmenopausal). High variability in these results
indicate that the associations between study variables vary with different phases of the
menopausal transition, with perimenopausal women often exhibiting weaker
associations compared to premenopausal and postmenopausal women.
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CHAPTER 5

CONCLUSION

The present study explores: (1) the differences in age, physical function
performance, and physical activity among menopausal status groups, and (2) the
strength of the associations between age, menopausal status, physical function
performance, physical activity, and body composition in middle-aged women. Middleaged women are often underrepresented in research for a variety of reasons including
hormonal fluctuations (5,16) and pregnancy (18,19). Therefore, this study builds on
the understanding of these associations in an understudied population using both
standard measures in the existing literature and measures of physical function that
have not been previously tested in association with menopausal status. Further, this
study seeks to describe differences in correlates of physical function between
menopausal status groups that have been rarely (physical activity) or inconsistently
(body composition) reported using the sophisticated measurement techniques of
accelerometry and DXA
The results of this study refute the primary hypothesis that there would be
significant differences in physical function, physical activity, and body composition
between menopausal status groups, as the only significant difference found between
menopausal status groups was age. Similarly, the results of this study refute the
secondary hypothesis. Overall, in contrast to what has been seen in previous studies
(16,26,27), R2 and β values were low, indicating that, in this sample, total number of
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chronic medical conditions, age, and menopausal status were generally poor predictors
of physical function, physical activity, and body composition. Specifically,
menopausal status was not significantly and independently associated with any
measures of physical function, physical activity, or body composition when
controlling for total number of chronic medical conditions. With the same control
variables, age was significantly and independently associated with transfer task and
handgrip strength performance.
The null findings in this study may be a result of the fact that the study
participants exhibited somewhat higher physical function, higher physical activity, and
more optimal body composition compared to population norms and results from
similar studies. Specifically, the present study’s participants reported higher mean SF36 physical functioning subscale scores (94.71) compared to a mean score of 85.3
found in a study of 506 middle-aged women (24). Additionally, a study of 1,862
middle-aged adults found a mean of 6,801 steps per day (78) compared to a mean of
8,256 steps per day in this study and a study of 962 middle-aged women found a mean
of 29.2 minutes of MVPA per day (79) compared to 32.2 minutes of MVPA per day in
the present investigation. Furthermore, % fat was lower in this study (37.8%)
compared to population norms for women in United States (39.2% for ages 40-49,
41.7% for ages 50-59, and 42.4% for ages 60-69) (76). Thus, the present sample
appears healthier in these variables compared to the general population of middle-aged
women in the US, which may account for why the study results overall disagreed with
existing research in this area.
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This study’s findings that there are no associations between menopausal status
and physical function conflict with much of the existing body of literature. Sowers and
Tomey et al. (24) demonstrated that, when controlling for age, BMI, and smoking
behavior, self-reported menopausal status was associated with the objective physical
function measures of 3-stair ascent time, sit-to-stand time, and maximal gait velocity,
as well as self-report perceived physical functioning using the SF-36. A possible
reason why the present study’s findings conflict with those of Sowers and Tomey et al.
(28) is that the two investigations used different measures of objective physical
functioning; it is possible that some measures of objective physical functioning may
be more sensitive to change during the menopausal transition. Furthermore, the study
by Sowers and Tomey et al. (24) followed a 5-year longitudinal design and it is
feasible that longitudinal designs are optimal for identifying changes across the
menopausal transition, compared to a cross-sectional approach. Importantly, Sowers
and Tomey et al. (24) also used their own definition of menopausal status stages, as
opposed to the more established SWAN criteria, which may also impact their results.
Also in contrast with the present findings, a cross-sectional study by Tseng et
al. (28) and a longitudinal study by El Khoudary et al. (29) found significant
associations between menopausal status and the SF-36 physical functioning subscale
when controlling for age, with poorer self-perceived function in those who were
further along in the menopausal transition. While these studies used the SWAN
criteria for defining menopausal status, they both had a much larger sample size
(n=2236 and n=2495, respectively) than the current investigation (n=107) (28,29).
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Larger sample sizes may help ensure the sample is more representative of the selected
population.
Previous work done in London and Brazil (25,26) found significant
associations between menopausal status and the strength outcome of handgrip strength
when controlling for age. Therefore, findings related to our outcomes of interest may
be region/location specific and may only be generalizable to middle-aged women from
these areas. Both of these studies also used alternative measurements of menopausal
status to the SWAN criteria (25,26), which may have contributed to differences in
results. Kurina et al. (27) also found that associations between menopausal status and
grip strength in women in the United States were present but non-significant. This
study used the SWAN criteria, although it was longitudinal, which may account for
differences in results compared to the present study.
While the majority of pre-existing literature shows association between
menopausal status and physical function when controlling for age (24–27,29), several
available studies agree with the results of the present investigation and have found no
significant associations between these outcomes (25,26,28). For example, Tseng et al.
(28) found that natural gait velocity was not significantly associated with menopausal
status when controlling for age in women in the United States. Cooper et al. (25)
found that 30-second single-leg stand time and repeated chair stand performance were
not significantly associated with menopausal status when controlling for age.
Additionally, Da Câmara et al. (26) found that natural gait velocity and repeated chair
stands were not associated with menopausal status when controlling for age, in a
cross-sectional study that used a chair stand task similar to the present study’s 30-
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second chair stand task. It is possible that there are no significant differences in
physical function among menopausal status groups, but it is also possible that the
objective measures of physical function utilized in these studies (25,26) and the
present study are not sensitive enough to detect smaller differences in physical
function that may exist between menopausal status groups. In regards to physical
activity, the present results align with cross-sectional studies using self-report physical
activity (16,26), but contrast with a longitudinal study using accelerometer-measured
physical activity (34). It is possible that study design accounts for these conflicting
results, as cross-sectional studies may be less representative of individuals’ true
physical activity behaviors over time compared to longitudinal studies. The crosssectional nature of the present study may also be a limitation in that we are unable to
make any conclusions about causality.
The present study’s findings that there are no associations between menopausal
status and body composition when controlling for age agree with existing literature on
BMI (33,37,42,43), but disagree with previous work examining body fat and lean
mass (22,30,31,35,40). The majority existing studies support that weight gain (i.e.
increased BMI) is not associated with menopausal status when controlling for age
(33,37). In contrast, negative changes in body fat distribution (i.e. increases in visceral
abdominal fat) (22,30,31) and decreased lean mass (31,35,40) have been consistently
associated with menopausal status when controlling for age. In three studies assessing
US women with the SWAN criteria, DXA measurements, and longitudinal designs,
the menopausal transition was associated with increased visceral abdominal fat
(22,31), increased subcutaneous fat (22), increased total fat (35), decreased lean mass
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(49), and decreased skeletal muscle mass (35),when controlling for age. Two cross
sectional studies using alternative methods to define menopausal status similarly
found the menopausal transition to be associated with increased visceral abdominal fat
(30) and decreased lean mass (40) when controlling for age.
The present study did not demonstrate a between-group difference in physical
activity, unlike a prior study (34). As physical activity has been shown to be
associated with improved physical function and body composition in middle-aged
women (11), it is possible that elevated physical activity levels in the present sample
are responsible for combatting any adverse effects of age or menopausal status on
physical function and body composition in the current cohort. Furthermore, the
strength of the association between physical activity and other study variables,
including percent fat and physical function outcomes, vary greatly between
menopausal status groups, indicating that these relationships may vary in strength
across the menopausal transition. Specifically, it appears that physical function
measures are least associated with body composition and physical activity measures in
perimenopausal women and most strongly associated with body composition and
physical activity in premenopausal women, indicating that perhaps an unconsidered
variable is responsible for variability in physical function in these groups.
All studies have limitations. First, many of the variables in the present study
are highly associated with each other. For example, in middle-aged women, physical
function is associated with both physical activity and body composition (11), and body
composition and physical activity are associated with each other (20,22,62,67). Age
and menopausal status were also highly positively correlated in this study (r=0.78,
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p≤0.001). Due to these interrelations, it is difficult to differentiate individual
relationships. Furthermore, this study might be limited by the fact that it uses selfreport menopausal status as opposed to blood-draw hormonal determinants. Adding
blood-draw hormonal levels would provide a method of validating self-report
menopausal status and may also provide an explanation for mechanisms of any
observed changes in physical function, physical activity, and body composition over
the menopausal transition (5). Additionally, as with all studies, results of the present
study are only generalizable to populations similar to the study sample: communitydwelling, non-smoking women ages 40-64 who were free of orthopedic or other health
conditions preventing safe study participation. Notably, 98.13 percent of this sample
was Caucasian. It is also possible that the sample selected is not representative of the
true population it was attempting to represent. This study was advertised as an
opportunity for middle-aged women to learn more about their present physical activity
levels, physical function, and body composition; it is therefore possible that women
less interested in their physical health self-selected out of this study, whereas more
active women were more interested in learning about these characteristics. A final
potential limitation of this study is its relatively small sample size. Larger sample sizes
may be more representative of the actual population of non-smoking middle-aged
women, which might provide a more accurate picture of physical function and its
correlates in this population.
In conclusion, more research is still needed to help clarify the associations
between age, menopausal status, physical function, physical activity, and body
composition in middle-aged women. The present study supports that there are
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significant associations between age and two outcome measures: transfer task time and
handgrip strength. It is possible that the true associations between age and menopausal
status and the outcome measures of physical function, physical activity, and body
composition are weak to nonexistent, and that other factors are responsible for
variability in these outcome measures. However, it is also possible that the limitations
in this study have prevented the observation of significant associations. Future studies
would optimally be longitudinal in nature in order to monitor these variables over the
menopausal transition. Other measures of physical function such as maximal gait
velocity and 3-stair ascent time (24) should also be incorporated, as it is possible that
some measures of physical function are more sensitive to change and therefore, more
strongly associated with menopausal status than others. This research will help us
better understand the causes and correlates of physical function in middle aged
women. In turn, this understanding will help guide interventions to improve the
physical function limitations observed in approximately one fifth of middle aged
women (2,3), and could prevent the decline in physical functioning that accelerates
during older adulthood (9).
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TABLES

Table 1. Participant demographics (n=107)
Variable
Mean ± SD
Age (y)
53.31 ± 6.14
Height (cm)
163.35 ± 5.51
Weight (kg)
69.71 ± 14.48
BMI (kg/m²)
26.09 ± 5.11
FM (%)
37.77 ± 8.06
MFLM (%)
62.23 ± 8.06
Steps/day
8256.65 ± 3321.90
MVPA/day (min)
32.16 ± 24.49
LMVPA/day (min)
329.37 ± 75.65
TRANSFER time (s)
3.81 ± 0.99
UPGO time (s)
5.24 ± 0.85
STAND repetitions (reps)
20.23 ± 5.35
6MWT distance (m)
576.03 ± 67.49
LIFT time (s)
57.99 ± 9.48
LEPF-CS
0.10 ± 2.92
SF-36 PF
94.71 ± 7.66
HGS (kg)
53.31 ± 12.53

Range
40-64
150.60-177.60
44.30-118.30
17.63-42.93
18.99-55.84
44.16-81.01
3275.40-20301.83
2.00-113.14
170.00-609.00
1.53-6.75
2.38-7.37
10.00-38.00
429.30-734.31
38.84-80.66
-5.99-8.34
65.00-100.00
18.00-90.00

BMI = body mass index; FM = fat mass; MFLM = mineral-free lean mass; Steps/day
= average number of steps per day; MVPA/day = average minutes of moderate +
vigorous physical activity per day; LMVPA/day = average minutes of light +
moderate + vigorous physical activity; TRANSFER = transfer task; UPGO = 8-foot
up-and-go; STAND = 30-second chair stands; 6MWT = 6-minute walk test; LIFT =
lift and carry; LEPF-CS = lower extremity physical function composite score; SF-36
PF = Short Form 36 physical functioning subscale; HGS = average right + average left
handgrip strength
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Table 3a. Multiple regression for body composition and physical activity
Variables
B
SEB
p
β
95% CI
(a) BMI (R²=0.047, p=0.174)
Medical Conditions
0.03
0.02 0.147 0.14
[-.01,0.8]
Age
-0.02
0.01 0.139 -0.23
[-0.05,0.01]
Menopausal Status
0.07
0.11 0.542 0.09
[-0.15,0.28]
(b) Fat mass (R²=0.011, p=0.757)
Medical Conditions
0.25
0.32 0.430 0.08
[-0.38,0.88]
Age
-0.13
0.21 0.543 -0.10
[-0.53,0.28]
Menopausal Status
1.15
1.56 0.465 0.11
[-1.95,4.24]
(c) Mineral-free lean mass (R²=0.011, p=0.757)
Medical Conditions
-0.25
0.32 0.430 -0.08
[-0.88,0.38]
Age
0.13
0.21 0.543 0.10
[-0.28,0.53]
Menopausal Status
-1.15
1.56 0.465 -0.11
[-4.24,1.95]
(d) Total steps per day (R²=0.033, p=0.322)
Medical Conditions -117.81 129.03 0.363 -0.09 [-373.70,138.09]
Age
14.15
83.49 0.866 0.03 [-151.44,179.74]
Menopausal Status
576.22 636.36 0.367 0.14 [-685.85,1838.29]
(e) Moderate and vigorous PA per day (R²=0.049, p=0.157)
Medical Conditions
-1.67
0.94 0.079 -0.17
[-3.55,0.20]
Age
-0.14
0.61 0.819 -0.04
[-1.35,1.07]
Menopausal Status
5.19
4.65 0.268 0.17
[-4.04,14.41]
(f) Light, moderate, and vigorous PA per day (R²=0.017, p=0.614)
Medical Conditions
-0.08
2.96 0.978 0.00
[-5.96,5.79]
Age
0.42
1.92 0.826 0.03
[-3.38,4.23]
Menopausal Status
9.66
14.61 0.510 0.10
[-19.31,38.64]

R2
0.019a
0.043b
0.047c
0.006a
0.006b
0.011c
0.006a
0.006b
0.022c
0.007a
0.025b
0.033c
0.019a
0.019b
0.021c
0.000a
0.013b
0.017c

B = unstandardized regression coefficient; SEB = coefficients standard error; β =
standardized regression coefficient
* p≤0.05
** p≤0.001
a
value for a model using chronic medical conditions as an independent variable
b
value for a model using chronic medical conditions and age as independent variables
c
value for a model using chronic medical conditions, age, and menopausal status as
independent variables
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Table 3b. Multiple regression for physical function and strength
R²
Variables
B
SEB
p
β
95% CI
(g) Transfer task time (R²=0.14, p=0.001**)
Medical Conditions
0.06
0.04
0.126
0.14
[-0.02,0.13]
0.012a
Age
0.06
0.02
0.015*
0.36
[0.01,0.10]
0.123b
Menopausal Status
-0.03
0.18
0.876
-0.02
[-0.38,0.33]
0.115c
(h) 8-foot up-and-go time (R²=0.040, p=0.235)
Medical Conditions
0.05
0.03
0.141
0.14
[-0.02,0.11]
0.012a
Age
0.02
0.02
0.415
0.13
[-0.03,0.06]
0.022b
Menopausal Status
0.02
0.16
0.919
0.02
[-0.31,0.34]
0.012c
(i) 30-second chair stands (R²=0.030, p=0.363)
Medical Conditions
-0.17
0.21
0.422
-0.08
[[-0.58,0.25]
0.006a
Age
-0.14
0.14
0.298
-0.16
[-0.41,0.13]
0.03b
Menopausal Status
0.06
1.03
0.953
0.01
[-1.98,2.10]
0.03c
(j) 6-minute walk test distance (R²=0.022, p=0.512)
Medical Conditions
-3.91
2.64
0.141
-0.15
[-9.14,1.32]
0.21a
Age
-0.23
1.71
0.893
-0.02
[-3.61,3.15]
0.022b
Menopausal Status
-0.90 13.02
0.945
-0.01 [-26.72,24.92] 0.022c
(k) Lift and carry time (R²=0.059, p=0.099)
Medical Conditions
0.44
0.36
0.232
0.12
[-0.28,1.16]
0.014a
Age
0.40
0.24
0.091
0.26
[-0.07,0.87]
0.058b
Menopausal Status
-0.79
1.80
0.662
-0.07
[-4.35,2.78]
0.059c
(l) Lower extremity physical function composite score (R²=0.069, p=0.063)
Medical Conditions
-0.18
0.11
0.112
-0.15
[-0.40,0.04]
0.015a
Age
-0.11
0.07
0.150
-0.22
[-0.25,0.04]
0.051b
Menopausal Status
0.05
0.55
0.932
0.01
[-1.05,1.14]
0.042c
(m) SF-36 physical functioning subscale (R²=0.035, p=0.311)
Medical Conditions
-0.56
0.31
0.076
-0.18
[-1.17,0.06]
0.031a
Age
-0.02
0.19
0.912
-0.02
[-0.41,0.36]
0.034b
Menopausal Status
-0.47
1.47
0.749
-0.05
[-3.38,2.44]
0.035c
(n) Handgrip strength (R²=0.157, p=0.001**)
Medical Conditions
0.41
0.45
0.368
0.08
[-0.49,1.31]
0.006a
Age
-0.94
0.29
0.002* -0.46
[-1.52,-0.36]
0.153b
Menopausal Status
1.52
2.24
0.500
0.10
[-2.93,5.96]
0.157c
B = unstandardized regression coefficient; SEB = coefficients standard error; β =
standardized regression coefficient
* p≤0.05
** p≤0.001
a
value for a model using chronic medical conditions as an independent variable
b
value for a model using chronic medical conditions and age as independent variables
c
value for a model using chronic medical conditions, age, and menopausal status as
independent variables
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FIGURES

Figure 1. Study flow chart
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Figure 2a. Transfer task performance by menopausal status
Data shown as mean ± SE
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Figure 2b. 8-foot up-and-go performance by menopausal status
Data shown as mean ± SE
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Figure 2c. 30-second chair stands performance by menopausal status
Data shown as mean ± SE
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Figure 2d. 6-minute walk test performance by menopausal status
Data shown as mean ± SE
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Figure 2e. Lift and carry performance by menopausal status
Data shown as mean ± SE
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Figure 2f. Lower extremity physical function composite score by menopausal status
Data shown as mean ± SE
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Figure 2g. SF-36 physical functioning subscores by menopausal status
Data shown as mean ± SE
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Figure 2h. Handgrip strength sums by menopausal status
Data shown as mean ± SE
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APPENDICES

Appendix A. Women’s Health Improvement Initiative screening questionnaire
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Appendix B. Women’s Health Improvement Initiative informed consent
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Appendix C. Physical Activity Readiness Questionnaire (PAR-Q)
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Appendix D. Mini-Mental Status Examination
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Appendix E. ActiGraph Accelerometer Instructions
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Appendix F. ActiGraph Accelerometer Record of Wear
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Appendix G. 36-Item Short Form Survey (SF-36)
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